Pre-market Hot Trades in US Stocks
Carmax is down 9.91% in pre-market trading. Based on recent key news:
<ol>
<li>
On December 18, Carmax announced its third-quarter results, with net income declining year-on-year, leading to a pre-market drop in stock price. The company reported net income of $6.2 million, down from $12.5 million in the same period last year, and earnings per share fell from $0.81 to $0.43. Although it exceeded analyst expectations, the overall poor performance affected the stock price. Source: RTTNews
</li>
<li>
On December 18, Carmax announced it would lower retail profit margins to boost sales, raising concerns about its profitability in the market. The company plans to improve sales trends by reducing retail profit margins, which has intensified investor concerns about its profitability, putting pressure on the stock price. Source: RTTNews
</li>
<li>
On December 18, Carmax underwent leadership changes, with an interim CEO taking office, increasing market uncertainty about the company's future direction. David McCreight was appointed as interim president and CEO, and Tom Folliard took on the role of interim executive chairman, initiating the search for a permanent CEO, which added to market uncertainty. Source: CarMax announcement on the weak demand in the used car market and uncertain economic environment.
</li>
</ol>
Ucloudlink is up 8.37% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.
Top Gainers in Pre-market US Stocks
Athira Pharma is up 61.79% in pre-market trading. Based on recent key news:
<ol>
<li>On December 18, Athira Pharma submitted an 8-K filing showing significant progress in its R&amp;D efforts. This news boosted market confidence, leading to a substantial pre-market increase in stock price of 61.79%. The filing was disclosed by the SEC, ensuring the accuracy and authority of the information. The biotechnology sector has performed strongly recently.</li>
</ol>
Sable Offshore is up 44.54% in pre-market trading. Based on recent news:
<ol>
<li>
On December 17, Sable Offshore received confirmation from PHMSA that its pipeline is classified as an interstate facility. This reclassification shifts regulatory oversight to PHMSA, with the pipeline connecting the Santa Ynez Unit and Pentland Station, and PHMSA's review includes on-site inspections and records. This news has enhanced market confidence in the company's future operations, driving up the stock price.
</li>
<li>
On December 18, Roth MKM analyst Leo Mariani maintained a buy rating on Sable Offshore and set a target price of $22. Mariani is a five-star analyst in the energy sector, with an average return rate of 24.9%. The analyst's positive rating further boosted investor confidence
On December 18, Sable Offshore's Las Flores pipeline system was considered &#34;active&#34; by PHMSA. Previously, the pipeline had been classified as an intrastate pipeline since 2016 and was regulated by OSFM. This news indicates that the company has made progress in compliance, further driving up the stock price. The energy sector has performed strongly recently, and regulatory changes have had a positive impact.
</li>
</ol>
Urban-Gro rose 35.98% in pre-market trading, with no significant news recently. Trading is active, and there is a clear flow of funds. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation

Carmax pre-market down 9.91%; Ucloudlink pre-market up 8.37%; Athira Pharma pre-market up 61.79%; Sable Offshore pre-market up 44.54%; Urban-Gro pre-market up 35.98%

Pre-market hot trades in US stocks: Carmax pre-market down 9.91%; Ucloudlink pre-market up 8.37%